Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

269 - Good vs. bad science: how to read and understand scientific studies

Watch the full episode and view show notes here: https://bit.ly/47VnNbz Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ This special episode is a rebroadcast of AMA #30, now made available to everyone, in which Peter and Bob Kaplan dive deep into all things related to studying studies to help one sift through the noise to find the signal. They define various types of studies, how a study progresses from idea to execution, and how to identify study strengths and limitations. They explain how clinical trials work, as well as biases and common pitfalls to watch out for. They dig into key factors that contribute to the rigor (or lack thereof) of an experiment, and they discuss how to measure effect size, differentiate relative risk from absolute risk, and what it really means when a study is statistically significant. Finally, Peter lays out his personal process when reading through scientific papers. We discuss: 0:00:00 - Intro 0:00:18 - The ever-changing landscape of scientific literature 0:03:19 - The process for a study to progress from idea to design to execution 0:06:39 - Various types of studies and how they differ 0:19:14 - The different phases of clinical trials 0:28:32 - Observational studies and the potential for bias 0:49:27 - Experimental studies: randomization, blinding, and other factors that make or break a study 1:03:49 - Power, p-values, and statistical significance 1:16:21 - Measuring effect size: relative risk vs. absolute risk, hazard ratios, and “number needed to treat” 1:26:39 - How to interpret confidence intervals 1:34:15 - Why a study might be stopped before its completion 1:43:01 - Why only a fraction of studies are ever published and how to combat publication bias 1:53:45 - Why certain journals are more respected than others 1:57:54 - Peter’s process when reading a scientific paper -------- About: The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 70 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more. Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. Learn more: https://peterattiamd.com Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

Peter AttiahostBob Kaplanhost
Sep 4, 20232h 2mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Peter Attia and Bob Kaplan Explain How to Read Scientific Studies

  1. Peter Attia and Bob Kaplan walk through how a study moves from hypothesis, null hypothesis, design, power analysis, ethics approval and pre-registration to execution, and how observational, experimental and meta-analytic studies differ.
  2. They explain how bias and confounding such as healthy user bias, recall bias with food frequency questionnaires, and performance bias can undermine observational studies and even randomized trials, using examples like PREDIMED and a hypothetical potato diet trial.
  3. The statistical core covers power, p-values, relative versus absolute risk, hazard ratios, number needed to treat and confidence intervals, with worked numeric examples showing why effect size and uncertainty matter.
  4. The discussion turns to why trials stop early (safety, benefit, futility), how peer review and publication bias work, how pre-registration and registered reports help, and how journal impact factor is calculated.
  5. Attia closes with his paper-reading routine: abstract, methods, figures and legends, then discussion, and stresses that skill comes with practice and that media reporting often lacks rigor.

IDEAS WORTH REMEMBERING

5 ideas

A meta-analysis is only as good as its constituent studies

Attia says pooling garbage studies yields a garbage meta-analysis, so you must examine each study within it, and the evidence pyramid wrongly implies meta-analyses always beat randomized trials.

Observational nutrition research is limited by healthy user bias and recall problems

People who avoid meat tend to differ in many health behaviors, and food frequency questionnaires depend on unreliable memory, so Attia argues causality cannot be inferred and that such questionnaires should be abandoned.

Randomized trials can still be biased

Attia describes performance bias, where one arm gets more attention or coaching, and notes PREDIMED had randomization problems because entire clinics were assigned to one group, requiring reanalysis.

Power determines whether a null result means anything

An underpowered study may fail to detect a real difference, while an overpowered one can flag clinically irrelevant effects as statistically significant, so sample size relative to effect size matters.

Relative risk without absolute risk can mislead

A 25% relative increase in breast cancer in the Women's Health Initiative was only four to five cases per thousand, and NNT, calculated from absolute risk reduction, shows how many people must be treated to prevent one event.

WORDS WORTH SAVING

5 quotes

So if you do a meta-analysis of a bunch of garbage studies, you get a garbage meta-analysis.

— Peter Attia

you can't really talk about relative risk without knowing absolute risk, and sometimes they don't give you enough data in the paper to do that, and it's infuriating actually.

— Peter Attia

when something doesn't work it is just as important as when it does work.

— Peter Attia

you could make a case that one of the most efficacious dietary interventions known to man is having somebody watch what you eat every meal.

— Peter Attia

you just have to roll up your sleeves and accept the fact that you're, you're not going to be able to read these things in the bathtub, uh, you know, on a lazy Sunday morning.

— Peter Attia

Hypothesis-driven study design and pre-registrationObservational versus experimental studiesPhases one to four of clinical trialsBias, confounding and healthy user effectPower, p-values and confidence intervalsRelative risk, hazard ratios and NNTPublication bias and journal impact factor

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.